BioSpace News Archive

Diadem srl, a company developing the first blood-based test for the early prediction of Alzheimer’s disease, announced top-line interim results from a global clinical validation study of its AlzoSure® Predict prognostic biomarker test, which can accurately predict progression to Alzheimer’s disease years before symptoms appear.

WISE Srl, a medical device company developing next-generation implantable electrodes for neuromonitoring, neuromodulation and brain-machine interfacing, announced the CE marking of its WISE Cortical Strip, a single use medical device intended to be used on the surface of the brain for intraoperative neurophysiological monitoring.

Iktos, a company specializing in Artificial Intelligence for new drug design, announced that it has entered into a Research Collaboration Agreement with Kadmon, a clinical-stage biopharmaceutical company based in New York, USA, pursuant to which, Iktos’s generative modelling artificial intelligence technology will be used to enable the rapid and cost-effective design of novel drug candidates for an undisclosed Kadmon drug discovery program.

BerGenBio ASA, a clinical-stage biopharmaceutical company developing novel, selective AXL kinase inhibitors for severe unmet medical need, provides top line data from BGBC020, a randomised Phase II clinical study evaluating the efficacy and safety of bemcentinib in hospitalised COVID-19 patients.

Photocure ASA, the Bladder Cancer Company, announces that notification was given to its partner and exclusive distributor, Genotests SpA by the Instituto de Salud Pública de Chile that the Marketing Authorization Application for Hexvix® has been accepted for regulatory review.

Data presented at hotline and late-breaking trial sessions at the EuroPCR 2021 congress demonstrated positive procedural performance, including low rates of paravalvular leakage and permanent pacemaker implementation, of the Boston Scientific ACURATE neo2™ Aortic Valve System within the investigator-initiated Early neo2 Registry1 and ITAL-neo Registry2 studies.

Amsterdam, the Netherlands – Royal Philips, a global leader in health technology, announced the European availability of new innovations in its unique portfolio of solutions that integrate imaging, devices, software, informatics and services at each point in a cardiac patient’s journey at EuroPCR 2021.

BioNTech SE, announced that the Supervisory Board has appointed Jens Holstein to the Management Board as Chief Financial Officer.

New plant will produce drug delivery devices, employ 150 people in 2024 and up to 600 when full operations start in 2030

LAVA Therapeutics N.V., a biotechnology company focused on applying its expertise in bispecific gamma-delta T cell engagers to transform cancer therapy, announced that Stephen Hurly, chief executive officer, will present at the 2021 UBS Global Healthcare Virtual Conference on Wednesday, May 26, 2021 at 1:00 p.m. ET.